Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 2 clinical trials
Bisphosphonates for Prevention of Post-Denosumab Bone Loss

The primary goal of the study is to assess the extent to which bisphosphonate therapy will prevent decreases in bone mass that may occur after cessation of denosumab in premenopausal women with

forteo
teriparatide
bisphosphonate therapy
bisphosphonate
denosumab
  • 78 views
  • 03 Mar, 2022
Alendronate in an Weekly Effervescent Tablet Formulation Following Denosumab Discontinuation (BAD)

recommends that patients who discontinue denosumab should continue to receive either intravenous (iv) or oral (peros) bisphosphonate therapy for some time. The study aims to investigate changes in the BMD of

alendronate
bisphosphonate therapy
binosto 70mg effervescent tablet
denosumab
bone mineral density
  • 28 views
  • 17 Mar, 2022
  • 1 location